Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI

[1]  D. Globe,et al.  Treatment satisfaction and improvement in health‐related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity , 2013, Neurourology and urodynamics.

[2]  S. Biers,et al.  The past, present and future of augmentation cystoplasty , 2012, BJU international.

[3]  Shu-Hsin Liu,et al.  Effect of repeated detrusor onabotulinumtoxina injections on bladder and renal function in patients with chronic spinal cord injuries , 2011, Neurourology and urodynamics.

[4]  D. Penson,et al.  Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity , 2011, World Journal of Urology.

[5]  A. Gall,et al.  The relationship between bladder management and health-related quality of life in patients with spinal cord injury in the UK , 2010, Spinal Cord.

[6]  B. Çelik.  Quality of Life in Spinal Cord Injury , 2010 .

[7]  J. Pannek,et al.  Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. , 2009, Urology.

[8]  G. Amarenco,et al.  Critères de décision et recommandations de bonne pratique clinique pour la première injection intradétrusorienne de toxine botulique A dans le traitement de l’hyperactivité neurogène du détrusor , 2009 .

[9]  G. Amarenco,et al.  Recommandations de bonne pratique clinique pour le suivi des patients neurologiques après injection de toxine botulique intradétrusorienne , 2009 .

[10]  G. Karsenty,et al.  [Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]. , 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[11]  B. Schurch,et al.  Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. , 2008, European urology.

[12]  B. Schurch,et al.  Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. , 2006, Urology.

[13]  M. Brin,et al.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. , 2005, The Journal of urology.

[14]  G. Amarenco,et al.  Terminologie des troubles fonctionnels du bas appareil urinaire : Adaptation française de la terminologie de l’International Continence Society , 2004 .

[15]  G. Guyatt,et al.  Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire. , 2004, Archives of physical medicine and rehabilitation.

[16]  P. Rubenwolf.  [Prognostic value of urodynamic testing in myelodysplastic patients]. , 2003, Aktuelle Urologie.

[17]  R. Hamid,et al.  Surgical and patient reported outcomes of 'clam' augmentation ileocystoplasty in spinal cord injured patients. , 2003, European urology.

[18]  M. Quek,et al.  Long-term urodynamics followup of bladder augmentation for neurogenic bladder. , 2003, The Journal of urology.

[19]  R. Weiss,et al.  Prognostic value of urodynamic testing in myelodysplastic patients. 1981. , 1981, The Journal of urology.

[20]  P. Marquis,et al.  Quality of Life in Spinal Cord Injury Patients with Urinary Difficulties , 2000, European Urology.

[21]  R. Hewitt,et al.  Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. , 1998, Urology.

[22]  G. Savić,et al.  Long-term survival in spinal cord injury: a fifty year investigation , 1998, Spinal Cord.

[23]  T. Zampieri,et al.  Bladder hypocompliance in the spinal cord injury population. , 1989, The Journal of urology.

[24]  P I Terasaki,et al.  Long-term survival. , 1988, Clinical transplants.